Secondary Logo

Institutional members access full text with Ovid®

The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA

Jin, Xuejing, PhD; Al Sayah, Fatima, PhD; Ohinmaa, Arto, PhD; Marshall, Deborah A., PhD; Smith, Christopher, MBA; Johnson, Jeffrey A., PhD

Clinical Orthopaedics and Related Research®: February 06, 2019 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/CORR.0000000000000662
Basic Research: PDF Only

Background As a generic measure of health-related quality of life among patients awaiting THA or TKA, the three-level version of the EQ-5D (EQ-5D-3L), which has three response levels of severity (no problems, some problems, and extreme problems/unable) to five questions, is widely used. Previous studies indicated that the ceiling effect of the EQ-5D-3L limits its application. The five-level version of the EQ-5D (EQ-5D-5L) was developed to enhance the measurement properties of the tool by adding two levels: slight problems and severe problems. However, only a few small studies have compared the EQ-5D-3L and EQ-5D-5L in patients awaiting THA and TKA.

Questions/purposes The purpose of this study was to examine the performance of the EQ-5D-3L and EQ-5D-5L among patients awaiting THA or TKA in terms of (1) response patterns, (2) convergent construct validity, (3) known-group validity, and (4) informativity and discriminatory power.

Methods This is a retrospective analysis of the Alberta Bone and Joint Health Data Repository, which recorded information on all patients receiving hip or knee arthroplasties between April 2010 and March 2017 in Alberta, Canada (n = 37,377). Patients receiving THA or TKA and who completed the EQ-5D and WOMAC at baseline (presurgery) were included in this study (n = 24,766). The EQ-5D-3L was administered to all patients in 2010, and was gradually replaced by the EQ-5D-5L between 2013 and 2016; the EQ-5D-5L reached full application in all clinics by 2017.

A propensity score was used to match patients 1:1 who completed either the EQ-5D-3L or EQ-5D-5L before surgery. Response patterns have been explored using ceiling and floor effects and distribution across severity levels of each dimension. Convergent construct validity was examined using Spearman’s correlation (rho) against the WOMAC. Known-group validity was examined by gender, preoperative risk factors, mental health, obesity, and WOMAC physical function score. Informativity and discriminatory power were examined using the Shannon (H’) and Shannon evenness (J’) indices. A total of 3446 pairs of patients awaiting THA (55% women; mean age, 66 years) and 5428 pairs of patients awaiting TKA (59% women; mean age 67 years) were included in this analysis; the study group included all patients who were kept in the propensity score matching.

Results Ceiling and floor effects were comparable and small (less than 0.5%) for both versions; the responses across severity levels for each dimension were more evenly distributed for the EQ-5D-5L. Convergent construct validity was stronger for the EQ-5D-5L as it consistently had stronger correlations with the WOMAC overall and domain scores than the EQ-5D-3L (rho(3L-THA), -0.77 to -0.31; rho(3L-TKA), -0.71 to -0.24; rho(5L-THA), -0.71 to -0.17; rho(5L-TKA), -0.64 to -0.17; all p values < 0.001). The hypotheses of known-group analyses were confirmed for both versions. The EQ-5D-5L demonstrated stronger informativity and discriminatory power than the EQ-5D-3L, particularly for the mobility dimension (THA, H’(5L/3L)=1.66/0.37, J’(5L/3L)=0.72/0.23; TKA, H’(5L/3L)=1.66/0.41, J’(5L/3L)=0.71/0.26).

Conclusions This study demonstrates the superior construct validity, and informativity and discriminatory power of the EQ-5D-5L compared with the EQ-5D-3L among patients awaiting THA or TKA.

Clinical Relevance Compared with the three-level version, the five-level version of the EQ-5D differentiates between patients awaiting THA and TKA much better based on their mobility, which is a key health aspect or outcome in these patients. Our findings suggest that the EQ-5D-5L is more appropriate for this population.

X. Jin, F. Al Sayah, A. Ohinmaa, J. A. Johnson, School of Public Health, University of Alberta, Edmonton, Alberta, Canada

D. A. Marshall, Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada

C. Smith, Alberta Bone & Joint Health Institute, Calgary, Alberta, Canada

J. A. Johnson, School of Public Health, University of Alberta, 2-040 Li Ka Shing Centre for Health Research Innovation, Edmonton, Alberta T6G 2E1, Canada, Email:

The institution of one or more of the authors (JAJ) has received, during the study period, funding from the EuroQol Research Foundation. One of the authors certifies that he (JAJ) is a member of the Board of Directors of the EuroQol Research Foundation, which holds the copyright for the EQ-5D instruments.

One of the authors certifies that she (DAM), or a member of her immediate family, has received or may receive payments or benefits, during the study period, personal consulting fees in an amount less than USD 10,000 from Optum Insight (Eden Prairie, MN, USA), personal consulting fees in an amount less than USD 10,000 from the Research Triangle Institute (Research Triangle Park, NC, USA); personal consulting fees in an amount less than USD 10,000, from Abbvie (North Chicago, IL, USA) all outside the submitted work.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

Clinical Orthopaedics and Related Research® neither advocates nor endorses the use of any treatment, drug, or device. Readers are encouraged to always seek additional information, including FDA approval status, of any drug or device before clinical use.

Each author certifies that his or her institution waived approval for the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.

This work was performed at the Alberta Bone and Joint Health Institute in Calgary, Alberta, Canada, and the School of Public Health, University of Alberta in Edmonton, Alberta, Canada.

Received August 21, 2018

Accepted January 09, 2019

© 2019 Lippincott Williams & Wilkins LWW
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website